Effect of intravenous iron (ferric derisomaltose) on haemoglobin and clinical events according to age in patients with heart failure and iron deficiency in a randomised trial (ironman)

被引:0
|
作者
Squire, Iain [1 ]
Cowburn, Peter [2 ]
Lang, Ninian [3 ]
Critoph, Chris [4 ]
Schiff, Rebekah [5 ]
Szwejkowski, Ben [6 ]
Petrie, Mark [7 ]
Kalra, Paul [8 ]
Ford, Ian [7 ]
Ray, Robin [9 ]
Donnelly, Patrick [10 ]
Clelland, John G. F. [7 ]
Robertson, Michele [7 ]
Thomson, Elizabeth [7 ]
Banerjee, Prithwish [11 ]
Nageh, Thuraia [12 ]
机构
[1] Glenfield Hosp, Dept Cardiovasc Sci, Cardiovasc Res Ctr, Leicester, Leics, England
[2] Univ Hosp Southampton, Southampton, Hants, England
[3] Univ Glasgow, Glasgow, Lanark, Scotland
[4] Univ Hosp Bournemouth, Bournemouth, Dorset, England
[5] Guys & St Thomas NHS Trust, London, England
[6] Ninewells Hosp & Med Sch, Dundee, Scotland
[7] Univ Glasgow, Glasgow, Lanark, Scotland
[8] Portsmouth Hosp Univ NHS Trust, Portsmouth, Hants, England
[9] St Georges Hosp NHS Trust, London, England
[10] Univ HF Leicester, Leicester, Leics, England
[11] Univ Hosp Coventry & Warwickshire, Coventry, W Midlands, England
[12] Mid & South Essex NHS Trust, Southend On Sea, Essex, England
关键词
IRONMAN; HEART FAILURE; IRON DEFICIENCY;
D O I
10.1136/heartjnl-2023-BCS.134
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
134
引用
收藏
页码:A154 / A155
页数:2
相关论文
共 50 条
  • [41] A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
    Bhandari, S.
    Allgar, V
    Lamplugh, A.
    Macdougall, I
    Kalra, P. A.
    BMC NEPHROLOGY, 2021, 22 (01)
  • [42] Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency
    Ponikowski, Piotr
    van Veldhuisen, Dirk J.
    Comin-Colet, Josep
    Ertl, Georg
    Komajda, Michel
    Mareev, Viacheslav
    McDonagh, Theresa
    Parkhomenko, Alexander
    Tavazzi, Luigi
    Levesque, Victoria
    Mori, Claudio
    Roubert, Bernard
    Filippatos, Gerasimos
    Ruschitzka, Frank
    Anker, Stefan D.
    EUROPEAN HEART JOURNAL, 2015, 36 (11) : 657 - 668
  • [43] Ferric derisomaltose versus usual care in patients with heart failure, reduced ejection fraction, and iron deficiency: a short-term UK cost-utility analysis based on the IRONMAN RCT
    Pollock, R.
    Kalra, P. R.
    Mcmurray, J. J., V
    Graham, F. J.
    Pellicori, P.
    Cleland, J. G. F.
    Ford, I
    EUROPEAN HEART JOURNAL, 2024, 45
  • [44] Effect of Intravenous Iron Therapy in Patients With Heart Failure and Iron Deficiency: A MetaAnalysis of Randomized Controlled Trials
    Jaiswal, Vikash
    Jaiswal, Akash
    Agrawal, Vibhor
    Ang, Song Peng
    Kalra, Kriti
    Bisht, Himanshi
    Tripathi, Apoorva
    Biswas, Monodeep
    CIRCULATION, 2023, 148
  • [45] Intravenous Ferric Carboxymaltose in Heart Failure With Iron Deficiency The FAIR-HF2 DZHK05 Randomized Clinical Trial
    Anker, Stefan D.
    Friede, Tim
    Butler, Javed
    Talha, Khawaja M.
    Placzek, Marius
    Diek, Monika
    Nosko, Anna
    Stas, Adriane
    Kluge, Stefan
    Jarczak, Dominik
    Deheer, Geraldine
    Rybczynski, Meike
    Bayes-Genis, Antoni
    Boehm, Michael
    Coats, Andrew J. S.
    Edelmann, Frank
    Filippatos, Gerasimos
    Hasenfuss, Gerd
    Haverkamp, Wilhelm
    Lainscak, Mitja
    Landmesser, Ulf
    Macdougall, Iain C.
    Merkely, Bela
    Pieske, Burkert M.
    Pinto, Fausto J.
    Rassaf, Tienush
    Visser-Rogers, Jennifer K.
    Rosano, Giuseppe
    Volterrani, Maurizio
    von Haehling, Stephan
    Anker, Markus S.
    Doehner, Wolfram
    Ince, Hueseyin
    Koehler, Friedrich
    Savarese, Gianluigi
    Khan, Muhammad Shahzeb
    Rauch-Kroehnert, Ursula
    Gori, Tommaso
    Trenkwalder, Teresa
    Akin, Ibrahim
    Paitazoglou, Christina
    Kobielusz-Gembala, Iwona
    Kuthi, Luca
    Frey, Norbert
    Licka, Manuela
    Kaeaeb, Stefan
    Laugwitz, Karl-Ludwig
    Ponikowski, Piotr
    Karakas, Mahir
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,
  • [46] Iron deficiency screening and intravenous iron in patients followed by a heart failure clinic and hospitalised for acute heart failure
    Boisvert, J.
    Morin, R.
    Leclerc, V.
    Methot, J.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 : 423 - 423
  • [47] Clinical outcomes of intravenous iron therapy in patients with heart failure and iron deficiency: Meta-analysis and trial sequential analysis of randomized clinical trials
    Bhatia, Kirtipal
    Sabharwal, Basera
    Gupta, Kartik
    Lopez, Persio D.
    Kaur, Arpanjeet
    Bhatia, Harsimran K.
    Gandhi, Kruti Dhaval
    Niroula, Shailesh
    Correa, Ashish
    Birati, Edo Y.
    Argulian, Edgar
    Fox, Arieh
    Mahmood, Kiran
    JOURNAL OF CARDIOLOGY, 2024, 83 (02) : 105 - 112
  • [48] Intravenous iron therapy in acute decompensated heart failure patients with iron deficiency anaemia
    Youssef, G.
    Kamal, A.
    Diab, R.
    Hamid, M. Abdel
    EUROPEAN HEART JOURNAL, 2017, 38 : 1231 - 1231
  • [49] Intravenous iron in patients with heart failure and iron deficiency: an updated meta-analysis
    Graham, Fraser J.
    Pellicori, Pierpaolo
    Kalra, Paul R.
    Ford, Ian
    Bruzzese, Dario
    Cleland, John G. F.
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (04) : 528 - 537
  • [50] Intravenous iron supplementation is state of the art therapy in patients with heart failure and iron deficiency
    Doehner, Wolfram
    von Haehling, Stephan
    EUROPEAN JOURNAL OF HEART FAILURE, 2019, 21 (09) : 1165 - 1165